,address1,address2,city,state,zip,country,phone,website,industry,sector,longBusinessSummary,fullTimeEmployees,companyOfficers,compensationAsOfEpochDate,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,payoutRatio,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,enterpriseValue,profitMargins,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,bookValue,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,returnOnAssets,freeCashflow,operatingCashflow,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,14785 Omicron Drive,Suite 104,San Antonio,TX,78245,United States,210-677-6000,https://www.oncovista.com,Biotechnology,Healthcare,"OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.",2,"{'maxAge': 1, 'name': 'Dr. Alexander L. Weis Ph.D.', 'age': 72, 'title': 'Chairman, CEO, Pres, CFO, Principal Accounting Officer and Sec.', 'yearBorn': 1950, 'fiscalYear': 2014, 'totalPay': 322000, 'exercisedValue': 0, 'unexercisedValue': 0}",1419984000,86400,4,0.0002,0.0001,0.0001,0.0001,0.0002,0.0001,0.0001,0.0001,0.0,-52.0778,100,100,929,11,11,0.0,0.0,0,0,558337,0.0001,0.0002,0.000198,0.0001755,0.0,0.0,USD,420383,0.0,23558500,0.0,0.0,-0.28,1419984000,1451520000,1443571200,-3270377,-0.0,1:1,1193616000,-0.123,PNK,EQUITY,OVIT,OVIT,ONCOVISTA INNOVATIVE THERAPIES ,"OncoVista Innovative Therapies, Inc.",1193405400,America/New_York,EDT,-14400000,0.0001,none,61270,0.003,-3404057,479298,0.01,0.01,-23.5768,-635235,-264361,0.0,0.0,0.0,USD,
